News | Cardiovascular Ultrasound | October 15, 2020

GE Healthcare Receives FDA Clearance for AI-powered Cardiovascular Ultrasound System

The Vivid Ultra Edition, AI-powered cardiovascular ultrasound system is designed to shorten diagnostic exam time and improve measurement consistency

GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

October 13, 2020 — GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

Methodical assessments of heart function are key in echocardiography but can be tedious and timeconsuming to acquire. High quality data acquisition and operator skill are key elements to achieve accurate and complete exams. And, as patients undergo subsequent monitoring exams, the reproducibility of exam assessments is key to identifying improvement or disease progression. Vivid Ultra Edition brings increased efficiencies to the scanning process for reduced exam time through up to 80% fewer clicks, 99% accuracy and less inter-operator variability. 

“We use AI Auto Measure – 2-D, AI Auto Measure – Spectrum Recognition, and Auto AFI together with Auto EF. We also use Scan Assist Pro, 4-D biplane and 4-D triplane. All of this in combination has saved us 7 to 10 minutes per scan, which is fantastic, so we really do have more time to spend with the patient,” said Rebecca Perry, Ph.D., cardiac sonography program stream coordinator, University of South Australia, in a Vivid Talk webinar.

Vivid Ultra Edition features leverage AI-driven, neural network-based algorithms designed to deliver repeatable and faster measurements in 2-D echo imaging:

• AI Auto Measure – Spectrum Recognition can semi-automatically detect the appropriate measurement of spectral Doppler images, enabling the system to fast-forward the path from scanning to measurements with 98% accuracy and 100% reproducibility. 

• AI Auto Measure – 2-D can detect the relevant points in the image used to derive key measurements of the left ventricle, performing comparable to human users with 100% reproducibility. 

• AI-based View Recognition can automatically detect with 99% accuracy and 100% reproducibility which standard 2D scan plane is acquired and store this label in the image file. Our AFI package is designed to use these data to automatically select views for strain analysis, streamlining workflow and increasing efficiency.  

“With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers’ two key challenges in echo exams – how time consuming the exam is and the degree of variability that exists in the quantitative results,” said Dagfinn Saetre, General Manager of Cardiovascular Ultrasound at GE Healthcare. “This package supports our vision of where we need to go with cardiovascular ultrasound: tools to support less variability and improved productivity. The Vivid Ultra Edition is a solid step in our strategic roadmap.” Vivid Ultra Edition also provides uncompromised image quality and advanced visualization and navigation capabilities:

• HD Color displays anatomy and jet using shadowing, reflections and transparency to enhance the 3-D perception.

• FlexiLight offers photorealistic images to help improve visualization of moving structures and depth perception of tissues.

• 4-D TTE Pediatric probe (6VDc) provides excellent 2-D and 4-D imaging for a range of pediatric patients from neonates to teenagers.

For more information: gevividultraedition.com/3d-map


Related Content

Feature | Cardiac Imaging

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

Home March 05, 2024
Home
News | Cardiac Imaging

PLEASE NOTE: This webinar has been postponed to a later date. A new date will be posted in the coming days. On March 25 ...

Home February 29, 2024
Home
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Home February 28, 2024
Home
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Home February 12, 2024
Home
News | Cardiac Imaging

November 16, 2023 — Cardiovascular diseases rank among the top causes of death across the world, and cardiac ...

Home November 16, 2023
Home
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Home September 21, 2023
Home
News | Cardiac Imaging

July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s ...

Home July 11, 2023
Home
Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

Home July 10, 2023
Home
News | Cardiac Imaging

June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home June 29, 2023
Home
News | Cardiac Imaging

June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

Home June 26, 2023
Home
Subscribe Now